BTIG notes Arvinas (ARVN) is down about 7% today, which the firm thinks is due to investors seeing a negative read-through to Arvinas from data ...

BTIG raised the firm’s price target on On Holding (ONON) to $67 from $64 and keeps a Buy rating on the shares as part of a broader research ...

Fintel reports that on December 10, 2024, BTIG initiated coverage of Nurix Therapeutics (NasdaqGM:NRIX) with a Buy ...

Kelly’s departure “does not instill confidence” but shouldn’t affect the robot developer’s timeline for a regulatory ...